rs12051723
From SNPedia
Orientation | plus |
Stabilized | plus |
Make rs12051723(G;G) |
Make rs12051723(G;T) |
Make rs12051723(T;T) |
Reference | GRCh38 38.1/141 |
Chromosome | 17 |
Position | 80350459 |
Gene | RNF213 |
is a | snp |
is | mentioned by |
dbSNP | rs12051723 |
dbSNP (classic) | rs12051723 |
ClinGen | rs12051723 |
ebi | rs12051723 |
HLI | rs12051723 |
Exac | rs12051723 |
Gnomad | rs12051723 |
Varsome | rs12051723 |
LitVar | rs12051723 |
Map | rs12051723 |
PheGenI | rs12051723 |
Biobank | rs12051723 |
1000 genomes | rs12051723 |
hgdp | rs12051723 |
ensembl | rs12051723 |
geneview | rs12051723 |
scholar | rs12051723 |
rs12051723 | |
pharmgkb | rs12051723 |
gwascentral | rs12051723 |
openSNP | rs12051723 |
23andMe | rs12051723 |
SNPshot | rs12051723 |
SNPdbe | rs12051723 |
MSV3d | rs12051723 |
GWAS Ctlg | rs12051723 |
GMAF | 0.14 |
Max Magnitude | 0 |
? | (G;G) (G;T) (T;T) | 28 |
---|---|---|
|
GWAS snp | |
---|---|
PMID | [PMID 23118302] |
Trait | Lipoprotein-associated phospholipase A2 activity change in response to statin therapy |
Title | Genome-wide association study evaluating lipoprotein-associated phospholipase A2 mass and activity at baseline and after rosuvastatin therapy. |
Risk Allele | T |
P-val | 3E-6 |
Odds Ratio | 2.20 [1.22-3.18] percent increase |